Preserved measles immunity after allogeneic hematopoietic stem cell transplantation in a cohort of mainly αβ T-cell-depleted graft recipients
- 6 October 2025
- journal article
- other
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 61 (1) , 92-94
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Measles Foci Reduction Neutralization Test (FRNT)2024
- Sex and age as determinants of the seroprevalence of anti-measles IgG among European healthcare workers: A systematic review and meta-analysisVaccine, 2022
- αβ T-cell graft depletion for allogeneic HSCT in adults with hematological malignanciesBlood Advances, 2021
- Persistence of Measles Antibodies After 2 Doses of Measles Vaccine in a Postelimination EnvironmentArchives of Pediatrics & Adolescent Medicine, 2007
- Comparison of the neutralizing and ELISA antibody titres to measles virus in human sera and in gamma globulin preparationsMedical Microbiology and Immunology, 2007
- Immune Containment and Consequences of Measles Virus Infection in Healthy and Immunocompromised IndividualsClinical and Vaccine Immunology, 2006
- Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host diseaseBone Marrow Transplantation, 2004
- Severe Measles in Immunocompromised PatientsJAMA, 1992